Profile data is unavailable for this security.
About the company
P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The Company supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from more than 250 disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. It has a network of more than 2,800 affiliated primary care providers across the country. Its local teams of health care professionals manage the care of thousands of patients in 23 counties across five states.
- Revenue in USD (TTM)1.27bn
- Net income in USD-57.77m
- Incorporated2020
- Employees400.00
- LocationP3 Health Partners Inc2045 W Grand Ave Ste B, Pmb # 82152CHICAGO 60612-1577United StatesUSA
- Phone+1 (312) 822-8897
- Fax+1 (302) 636-5454
- Websitehttps://ir.p3hp.org/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CytoDyn Inc | 0.00 | -51.69m | 148.75m | 12.00 | -- | -- | -- | -- | -0.055 | -0.055 | 0.00 | -0.1206 | 0.00 | -- | -- | 0.00 | -414.98 | -259.98 | -- | -- | -- | -- | -- | -235,303.80 | -- | -0.88 | -- | -- | -100.00 | -- | 62.14 | -- | -- | -- |
| Karyopharm Therapeutics Inc | 146.03m | -143.10m | 149.08m | 325.00 | -- | -- | -- | 1.02 | -1.25 | -1.25 | 1.28 | -1.19 | 0.4879 | 1.36 | 3.94 | 449,332.30 | -47.81 | -53.02 | -61.78 | -65.85 | 96.62 | 97.18 | -97.99 | -125.15 | 3.32 | -10.06 | 1.81 | -- | -7.03 | 36.93 | 13.43 | -- | -- | -- |
| Scilex Holding Co | 46.74m | -166.98m | 149.57m | 105.00 | -- | -- | -- | 3.20 | -1.25 | -1.25 | 0.3587 | -1.73 | 0.4977 | 5.61 | 1.67 | 445,171.40 | -121.73 | -- | -- | -- | 66.45 | -- | -244.59 | -- | 0.17 | -11.86 | -- | -- | 22.90 | -- | -614.67 | -- | -- | -- |
| ASP Isotopes Inc | 433.03k | -16.29m | 151.17m | 76.00 | -- | 9.28 | -- | 349.10 | -0.5016 | -0.5016 | 0.0131 | 0.3331 | 0.0216 | -- | -- | 5,697.76 | -81.39 | -- | -109.02 | -- | 32.09 | -- | -3,762.82 | -- | -- | -251.76 | 0.0378 | -- | -- | -- | -229.34 | -- | -- | -- |
| ProQR Therapeutics NV | 10.14m | -29.93m | 151.32m | 157.00 | -- | 3.56 | -- | 14.93 | -0.3695 | -0.3695 | 0.1251 | 0.5229 | 0.0616 | -- | 0.332 | 64,570.12 | -17.94 | -35.51 | -21.82 | -40.51 | -- | -- | -291.18 | -926.31 | -- | -- | 0.3229 | -- | 118.51 | 10.58 | 56.35 | -- | 34.45 | -- |
| Achieve Life Sciences Inc | 0.00 | -29.82m | 156.53m | 22.00 | -- | -- | -- | -- | -1.53 | -1.53 | 0.00 | -0.0684 | 0.00 | -- | -- | 0.00 | -120.85 | -86.31 | -860.46 | -119.59 | -- | -- | -- | -- | -- | -10.66 | 1.10 | -- | -- | -- | 29.60 | -- | -14.51 | -- |
| P3 Health Partners Inc | 1.27bn | -57.77m | 158.27m | 400.00 | -- | 0.411 | -- | 0.125 | -0.6494 | -0.6494 | 13.37 | 1.22 | 1.46 | -- | 13.23 | 3,165,938.00 | -21.46 | -- | -96.06 | -- | 2.50 | 0.1781 | -14.72 | -56.93 | -- | -10.33 | 0.1999 | -- | 20.67 | 70.58 | 78.61 | -- | -11.20 | -- |
| Capricor Therapeutics Inc | 25.18m | -22.29m | 159.09m | 101.00 | -- | 6.96 | -- | 6.32 | -0.8708 | -0.8708 | 0.9403 | 0.7256 | 0.4627 | -- | 4.61 | 249,287.80 | -40.96 | -54.12 | -82.59 | -75.13 | -- | -- | -88.52 | -316.25 | -- | -- | 0.13 | -- | 886.81 | 72.02 | 23.20 | -- | 45.27 | -- |
| INmune Bio Inc | 155.00k | -30.01m | 160.19m | 11.00 | -- | 4.14 | -- | 1,033.48 | -1.67 | -1.67 | 0.0086 | 2.12 | 0.0022 | -- | 0.0284 | 14,090.91 | -43.24 | -37.82 | -54.85 | -41.86 | -- | -- | -19,360.00 | -14,901.03 | -- | -13.06 | 0.2064 | -- | -58.56 | -- | -9.92 | -- | -- | -- |
| Candel Therapeutics Inc | 0.00 | -37.94m | 160.24m | 42.00 | -- | 12.46 | -- | -- | -1.31 | -1.31 | 0.00 | 0.4381 | 0.00 | -- | -- | 0.00 | -63.82 | -- | -76.57 | -- | -- | -- | -- | -- | -- | -73.91 | 0.6254 | -- | -100.00 | -- | -101.87 | -- | -- | -- |
| Zura Bio Ltd | 0.00 | -69.24m | 160.86m | 14.00 | -- | 2.71 | -- | -- | -4.38 | -4.38 | 0.00 | 1.36 | 0.00 | -- | -- | 0.00 | -49.98 | -- | -60.56 | -- | -- | -- | -- | -- | -- | -- | 0.0123 | -- | -- | -- | -2,050.99 | -- | -- | -- |
| Mediwound Ltd | 18.69m | -6.72m | 161.26m | 100.00 | -- | 4.96 | -- | 8.63 | -0.768 | -0.768 | 2.07 | 3.43 | 0.3209 | 6.28 | 2.87 | 186,860.00 | -11.53 | -24.48 | -14.35 | -32.92 | 19.15 | 43.27 | -35.94 | -38.43 | 4.33 | -- | 0.1674 | -- | -29.48 | 40.60 | 65.73 | -- | 64.66 | -- |
| Scpharmaceuticals Inc | 13.59m | -54.81m | 162.61m | 135.00 | -- | 4.36 | -- | 11.96 | -1.42 | -1.42 | 0.353 | 1.03 | 0.1243 | 0.7569 | -- | 100,688.90 | -50.13 | -38.23 | -55.33 | -42.31 | 71.96 | -- | -403.22 | -1,360.16 | 6.40 | -18.35 | 0.5105 | -- | -- | -- | -48.79 | -- | -- | -- |
| Greenwich Lifesciences Inc | 0.00 | -8.89m | 165.61m | 3.00 | -- | 24.72 | -- | -- | -0.6921 | -0.6921 | 0.00 | 0.5215 | 0.00 | -- | -- | 0.00 | -86.87 | -36.43 | -89.30 | -38.31 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -13.63 | -- | -- | -- |
| Adicet Bio Inc | 0.00 | -142.66m | 166.36m | 143.00 | -- | 0.5149 | -- | -- | -3.32 | -3.32 | 0.00 | 3.93 | 0.00 | -- | -- | 0.00 | -53.03 | -37.03 | -57.18 | -40.28 | -- | -- | -- | -748.46 | -- | -- | 0.00 | -- | -100.00 | -- | -104.41 | -- | 65.27 | -- |
Data as of Apr 19 2024. Currency figures normalised to P3 Health Partners Inc's reporting currency: US Dollar USD
15.99%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Columbia Wanger Asset Management LLCas of 31 Dec 2023 | 5.43m | 4.72% |
| Janus Henderson Investors US LLCas of 31 Dec 2023 | 3.78m | 3.28% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 2.33m | 2.03% |
| Alyeska Investment Group LPas of 31 Dec 2023 | 1.96m | 1.70% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 1.48m | 1.28% |
| EMFO LLCas of 31 Dec 2023 | 1.01m | 0.87% |
| Geode Capital Management LLCas of 31 Dec 2023 | 846.06k | 0.73% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 669.93k | 0.58% |
| Millennium Management LLCas of 31 Dec 2023 | 500.14k | 0.43% |
| HRT Financial LLCas of 31 Dec 2023 | 417.62k | 0.36% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
